Tv50717-Cns-40189
Research payments
$509,873
Through program year 2024, $509,873 in research payments was reported against Tv50717-Cns-40189, across 184 payments, paid by Teva Pharmaceuticals USA, Inc..
- Paid by
- Teva Pharmaceuticals USA, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $47,267 | 22 |
| 2023 | Research | $211,104 | 82 |
| 2022 | Research | $245,002 | 79 |
| 2021 | Research | $6,500 | 1 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Lauren Seeberger Charleston, WV Named on 22 payments
- Mohammad Nisar Okeechobee, FL Named on 22 payments
- Michael Soileau Georgetown, TX Named on 13 payments
- Gustavo Alva Brea, CA Named on 8 payments
- Pablo Coss San Antonio, TX Named on 7 payments
- Ira Glick Palo Alto, CA Named on 7 payments
- Nikolaus McFarland Orlando, FL Named on 7 payments
- Richard Jackson Boca Raton, FL Named on 7 payments
- Ryan Drake Canton, OH Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.